LEO Pharma required front end design of a major secondary manufacturing and packaging facility that included the manufacturing of small volume and large volume parenterals, solid dose and topical products.
The GMP Group assisted in the design and development of the facility in Eastern Europe, which was actually for a LEO Pharma partner.
The front end design, cost and planning packages were successfully delivered.
